1-2 of 2
Raphaelle Fanciullino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients

Guillaume Berton, Bochra Sedaki, Erwann Collomb, Sami Benachour, Michael Loschi, Bilal Mohty, Colombe Saillard, Yosr Hicheri, Camille Rouzaud, Valerio Maisano, Ferdinand Villetard, Evelyne D'Incan Corda, Aude Charbonnier, Jerome Rey, Marie Anne Hospital, Antoine Ittel, Norman Abbou, Raphaelle Fanciullino, Bérengère Dadone-Montaudié, Norbert Vey, Geoffroy Venton, Thomas Cluzeau, Anne Sophie Alary, Sylvain Garciaz
Journal: Blood
Blood (2023) 142 (Supplement 1): 2848.
https://doi.org/10.1182/blood-2023-180733
Published: 2023
Journal Articles

Cytidine Deaminase Status As a Predictive Marker Of Response and Toxicity In Patients With Haematological Malignancies Treated With Azacytidine Or Cytarabine

Cédric Mercier, MD, Raphaelle Fanciullino, PhD, Cindy Serdjebi, Joseph Ciccolini, PhD, Bertrand Pourroy, Gerard Milano, L’Houcine Ouafik, MD, PhD, Régis T Costello, Sr., MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3862.
https://doi.org/10.1182/blood.V122.21.3862.3862
Published: 2013